Published in Antimicrob Agents Chemother on November 01, 1980
Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother (1982) 3.84
Outbreak of nosocomial urinary tract infections caused by Serratia marcescens. J Clin Microbiol (1984) 1.20
Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli. Antimicrob Agents Chemother (1982) 1.03
Outer membrane and porin characteristics of Serratia marcescens grown in vitro and in rat intraperitoneal diffusion chambers. Infect Immun (1990) 1.02
Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae. Antimicrob Agents Chemother (1984) 0.91
Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates. Antimicrob Agents Chemother (1982) 0.75
HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1979) 10.60
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 7.01
Serial dilution antibiotic sensitivity testing with the microtitrator system. Am J Clin Pathol (1966) 6.14
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 3.88
LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity. Antimicrob Agents Chemother (1979) 3.49
Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole. Antimicrob Agents Chemother (1978) 3.29
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli. Antimicrob Agents Chemother (1980) 3.02
Comparison of techniques for measurement of in vitro antibiotic synergism. J Infect Dis (1979) 2.48
Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia. J Lab Clin Med (1975) 2.41
An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis (1976) 1.95
In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1979) 1.87
Hospital isolates of Serratia marcescens transferring ampicillin, carbenicillin, and gentamicin resistance to other gram-negative bacteria including Pseudomonas aeruginosa. Antimicrob Agents Chemother (1979) 1.75
Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new). Antimicrob Agents Chemother (1980) 1.62
Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.58
In vitro studies of 1-oxacephalosporin (LY 127935), a new beta-lactam antibiotic. Antimicrob Agents Chemother (1980) 1.46
Antibiotic resistance patterns of clinical isolates of Serratia marcescens. Antimicrob Agents Chemother (1975) 1.38
Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections. Antimicrob Agents Chemother (1977) 1.30
LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas. Antimicrob Agents Chemother (1979) 1.29
Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections. Antimicrob Agents Chemother (1976) 1.11
Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens. Am J Med (1979) 1.02
The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens. J Antibiot (Tokyo) (1978) 0.94
Activity of netilmicin compared with those of gentamicin and tobramycin against enterobacteria and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1977) 0.93
In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens. Microbiol Immunol (1979) 0.93
Synergism of aminoglycosides and carbenicillin against resistant strains of Serratia marcescens. J Antimicrob Chemother (1979) 0.89
In vitro studies on netilmicin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother (1977) 0.89
Antibiotic-resistant Serratia marcescens infection in a hospital. S Afr Med J (1979) 0.88
Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy. Arch Intern Med (1978) 0.86
Serratia marcescens: a study of the sensitivity of British isolates to antibacterial agents and their combinations. J Antimicrob Chemother (1978) 0.84
Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms. JAMA (1977) 0.84
Netilmicin synergy with carbenicillin or cefamandole against Serratia. J Antibiot (Tokyo) (1978) 0.81
Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis (1991) 4.82
Transferable tetracycline resistance in Clostridium difficile. Antimicrob Agents Chemother (1981) 2.56
Sequential outbreaks of infection due to Klebsiella pneumoniae in a neonatal intensive care unit: implication of a conjugative R plasmid. J Infect Dis (1980) 2.33
Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae. Antimicrob Agents Chemother (1980) 2.13
Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas. J Clin Microbiol (1992) 1.80
Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med (1992) 1.76
The effect of respirator training on the ability of healthcare workers to pass a qualitative fit test. Infect Control Hosp Epidemiol (1996) 1.52
Posterior fast atrioventricular node pathways: implications for radiofrequency catheter ablation of atrioventricular node reentrant tachycardia. J Am Coll Cardiol (1996) 1.46
Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation (2000) 1.43
Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med (1998) 1.33
Retrospective analysis of plasmid patterns in a study of burn unit outbreaks of infection due to Enterobacter cloacae. J Infect Dis (1983) 1.29
Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol (1999) 1.27
R-factor inheritance and plasmid content in mucoid Pseudomonas aeruginosa. Infect Immun (1978) 1.24
Mechanisms of idiopathic left ventricular tachycardia. J Cardiovasc Electrophysiol (1997) 1.22
Experimental pneumonitis and encephalitis caused by acanthamoeba in mice: pathogenesis and ultrastructural features. J Infect Dis (1975) 1.18
Idiopathic right ventricular outflow tract tachycardia: a clinical approach. Pacing Clin Electrophysiol (1996) 1.16
Nafcillin-induced agranulocytosis. JAMA (1975) 1.15
Nonlinear-dynamical arrhythmia control in humans. Proc Natl Acad Sci U S A (2001) 1.14
Therapeutic failures with miconazole. Antimicrob Agents Chemother (1978) 1.14
Adenosine-sensitive ventricular tachycardia: a conceptual approach. J Cardiovasc Electrophysiol (1996) 1.14
Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species. J Antimicrob Chemother (1997) 1.12
Isolation of Stomatococcus mucilaginosus from drug user with endocarditis. J Clin Microbiol (1987) 1.11
Comparison of a novel rectilinear biphasic waveform with a damped sine wave monophasic waveform for transthoracic ventricular defibrillation. ZOLL Investigators. J Am Coll Cardiol (1999) 1.10
Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother (1992) 1.10
Pneumonia and empyema infection associated with a Bacillus species that resembles B. alvei. J Clin Microbiol (1991) 1.07
Chromosomal DNA restriction endonuclease digestion patterns of beta-lactamase-producing Enterococcus faecalis isolates collected from a single hospital over a 7-year period. J Clin Microbiol (1996) 1.01
Endocarditis due to accidental penetrating foreign bodies. Am J Med (1976) 1.00
Effect of L-cysteine on the activity of penicillin antibiotics against Clostridium difficile. Antimicrob Agents Chemother (1985) 0.99
Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg (2000) 0.97
Antimicrobial susceptibility of mucoid Pseudomonas aeruginosa and their spontaneously occurring non-mucoid derivatives. J Antimicrob Chemother (1980) 0.95
Outbreak of Salmonella typhimurium gastroenteritis due to an imported strain resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole in a nursery. J Clin Microbiol (1984) 0.94
Ventricular arrhythmias in normal hearts. Cardiol Clin (2000) 0.93
Experimental Acanthamoeba infections in mice pretreated with methylprednisolone or tetracycline. Am J Pathol (1978) 0.92
Left ventricular geometry and function preceding neurally mediated syncope. Circulation (2000) 0.92
Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunitalphai2. J Clin Invest (1998) 0.91
Induction of neurally mediated syncope with adenosine. Circulation (1999) 0.90
Practical real-time computing system for biomedical experiment interface. Ann Biomed Eng (1999) 0.89
Aspergillus fumigatus endocarditis on a normal heart valve. South Med J (1983) 0.87
Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion. Antimicrob Agents Chemother (1981) 0.87
Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med (1987) 0.85
Do protective devices prevent needlestick injuries among health care workers? Am J Infect Control (1995) 0.83
Meningitis due to Neisseria mucosa: case report and review. Rev Infect Dis (1992) 0.82
An analysis of blood and body fluid exposures sustained by house officers, medical students, and nursing personnel on acute-care general medical wards: a prospective study. Infect Control Hosp Epidemiol (1991) 0.82
Echovirus meningomyeloencephalitis with administration of intrathecal immunoglobulin. J Neuropathol Exp Neurol (1985) 0.80
Nosocomial klebsiella infection in a neonatal unit: identification of risk factors for gastrointestinal colonization. Infect Control (1981) 0.80
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis. Antimicrob Agents Chemother (1993) 0.80
Failure of moxalactam in the treatment of neonatal sepsis and meningitis from Salmonella typhimurium. J Pediatr (1983) 0.80
Catecholamine facilitated reentrant ventricular tachycardia: uncoupling of adenosine's antiadrenergic effects. J Cardiovasc Electrophysiol (1999) 0.80
In vitro activity of cefoxitin, alone and in combination with aminoglycoside or other beta-lactam antibiotics against common gram-negative pathogens. Chemotherapy (1983) 0.79
Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol (2001) 0.79
The role of nonlinear dynamics in cardiac arrhythmia control. Heart Dis (2001) 0.79
Frequency of subacute resumption of isthmus conduction after ablation of atrial flutter. Am J Cardiol (2001) 0.78
Infections due to halophilic vibrios. Va Med (1985) 0.77
Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans. J Cardiovasc Pharmacol Ther (2001) 0.77
Complex AV nodal dynamics during ventricular-triggered atrial pacing in humans. Am J Physiol Heart Circ Physiol (2001) 0.77
Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope. Am Heart J (2001) 0.76
Vasodepressor syncope due to subclinical myocardial ischemia. J Cardiovasc Electrophysiol (1997) 0.75
Myocarditis associated with primary amebic (Naegleria) meningoencephalitis. Am J Clin Pathol (1974) 0.75
Rocky Mountain spotted fever: diagnostic dilemma of the atypical presentation. South Med J (1980) 0.75
A prospective study of the clinical utility of lymphocyte monitoring in the cardiac transplant recipient. Transplantation (1990) 0.75
Aminoglycoside predictions using a hand-held calculator: limitations of the model. Drug Intell Clin Pharm (1981) 0.75
A successful regimen for the prevention of seroconversion after transplantation of a heart positive for hepatitis B surface antigen. J Heart Lung Transplant (1992) 0.75
Grand rounds: current dilemmas in the treatment of urinary tract infections. Va Med (1980) 0.75
Transferrin receptors and CD4/CD8 lymphocyte ratios in rejection and infection in cardiac transplantation recipients. Transplant Proc (1990) 0.75
Emerging indications for cardiac pacing. Heart Dis (2002) 0.75
Existence of Sporothrix schenckii as a pulmonary saprophyte. Chest (1978) 0.75
Response of neurocardiac syncope to beta-blocker therapy: interaction between age and parasympathetic tone. Pacing Clin Electrophysiol (1997) 0.75
Heart rate changes preceding ventricular ectopy in patients with ventricular tachycardia caused by reentry, triggered activity, and automaticity. Am Heart J (1998) 0.75